166 related articles for article (PubMed ID: 16162908)
1. Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis.
Germano V; Picchianti Diamanti A; Baccano G; Natale E; Onetti Muda A; Priori R; Valesini G
Ann Rheum Dis; 2005 Oct; 64(10):1519-20. PubMed ID: 16162908
[No Abstract] [Full Text] [Related]
2. Infliximab-induced lupus-like reaction in a patient with psoriatic arthritis.
Pallotta P; Cianchini G; Ruffelli M; Puddu P
Rheumatology (Oxford); 2006 Jan; 45(1):116-7. PubMed ID: 16319094
[No Abstract] [Full Text] [Related]
3. Demyelinating disease in a patient with psoriatic arthritis and family history of multiple sclerosis treated with infliximab.
Ruiz-Jimeno T; Carvajal A; Mata C; Aurrecoechea E
J Rheumatol; 2006 Jul; 33(7):1457-8. PubMed ID: 16862660
[No Abstract] [Full Text] [Related]
4. Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy.
Izzi S; Francesconi F; Visca P; Altieri A; De Mutiis C; Trevisan G; Bonifati C
Dermatol Online J; 2010 May; 16(5):16. PubMed ID: 20492833
[TBL] [Abstract][Full Text] [Related]
5. Tuberculosis following therapy with infliximab may be refractory to antibiotic therapy.
Taylor JC; Orkin R; Lanham J
Rheumatology (Oxford); 2003 Jul; 42(7):901-2. PubMed ID: 12826707
[No Abstract] [Full Text] [Related]
6. Optic neuritis in a psoriatic arthritis patient treated by infliximab.
Minami-Hori M; Tsuji H; Takahashi H; Hanada K; Iizuka H
J Dermatol; 2013 Apr; 40(4):298-9. PubMed ID: 23289758
[No Abstract] [Full Text] [Related]
7. Disseminated Salmonella typhimurium infection secondary to infliximab treatment.
Fu A; Bertouch JV; McNeil HP
Arthritis Rheum; 2004 Sep; 50(9):3049. PubMed ID: 15457476
[No Abstract] [Full Text] [Related]
8. Eczematous drug eruption after infliximab.
Dumont-Berset M; Laffitte E; Gerber C; Dudler J; Panizzon RG
Br J Dermatol; 2004 Dec; 151(6):1272-3. PubMed ID: 15606528
[No Abstract] [Full Text] [Related]
9. Healing of psoriatic skin lesions, and improvement of psoriatic arthritis resistant to immunosuppressive drugs, after infliximab treatment.
Nikas SN; Voulgari PV; Takalou IP; Katsimbri P; Drosos AA
Ann Rheum Dis; 2005 Nov; 64(11):1665-7. PubMed ID: 16227426
[No Abstract] [Full Text] [Related]
10. Long term treatment of psoriatic arthritis with infliximab.
Yazdani-Biuki B; Wohlfahrt K; Mulabecirovic A; Mueller T; Hermann J; Graninger WB; Brezinschek HP; Brezinschek RI
Ann Rheum Dis; 2004 Nov; 63(11):1531-2; author reply 1532. PubMed ID: 15479917
[No Abstract] [Full Text] [Related]
11. Arthralgia as an adverse event to infliximab: a reactive arthritis or triggering of psoriatic arthritis? Successful management by switching to etanercept.
Moustou AE; Stratigos AJ; Vergou T; Gregoriou S; Georgala S; Danopoulou I
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):968-9. PubMed ID: 19207660
[No Abstract] [Full Text] [Related]
12. Psoriatic arthritis patients doing better on infliximab than etanercept.
Smith N; Gadsby K; Deighton C
Rheumatology (Oxford); 2007 Apr; 46(4):721-2. PubMed ID: 17314216
[No Abstract] [Full Text] [Related]
13. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
Chan CY; Browning JC; Larsen F; Hsu S
Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
[TBL] [Abstract][Full Text] [Related]
14. Hypertriglyceridaemia during treatment with adalimumab in psoriatic arthritis.
Stinco G; Piccirillo F; Patrone P
Br J Dermatol; 2007 Dec; 157(6):1273-4. PubMed ID: 17916219
[No Abstract] [Full Text] [Related]
15. Adalimumab-induced autoimmune hepatitis.
Adar T; Mizrahi M; Pappo O; Scheiman-Elazary A; Shibolet O
J Clin Gastroenterol; 2010 Jan; 44(1):e20-2. PubMed ID: 19593165
[TBL] [Abstract][Full Text] [Related]
16. Comparison of different outcome measures for psoriatic arthritis in patients treated with infliximab or placebo.
Vander Cruyssen B; De Keyser F; Kruithof E; Mielants H; Van den Bosch F
Ann Rheum Dis; 2007 Jan; 66(1):138-40. PubMed ID: 17178763
[No Abstract] [Full Text] [Related]
17. Occurrence of penile intraepithelial neoplasia following adalimumab treatment for psoriatic arthritis.
Kreuter A; Meyer MF; Wieland U
Arch Dermatol; 2011 Aug; 147(8):1001-2. PubMed ID: 21844477
[No Abstract] [Full Text] [Related]
18. Autoimmune hepatitis as an adverse effect of long-term methotrexate therapy.
Ksouda K; Affes H; Atheymen R; Ezzeddine M; Zeghal K; Hammami S
Indian J Pharmacol; 2014; 46(6):649-50. PubMed ID: 25538339
[TBL] [Abstract][Full Text] [Related]
19. Hyperpigmentation of the face following adalimumab treatment.
Blomberg M; Zachariae CO; Grønhøj F
Acta Derm Venereol; 2009; 89(5):546-7. PubMed ID: 19734995
[No Abstract] [Full Text] [Related]
20. Psoriasis onset during infliximab treatment: description of two cases.
Volpe A; Caramaschi P; Carletto A; Pieropan S; Bambara LM; Biasi D
Rheumatol Int; 2006 Oct; 26(12):1158-60. PubMed ID: 16738903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
